Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reply: Immunosuppressive cell death in cancer.

Literature DB >> 28480896

Reply: Immunosuppressive cell death in cancer.

Lorenzo Galluzzi¹, Aitziber Buqué², Oliver Kepp², Laurence Zitvogel³, Guido Kroemer⁴.

Abstract

Entities: Disease

Mesh：

Substances：
Immunosuppressive Agents

Year: 2017 PMID： 28480896 DOI： 10.1038/nri.2017.48

Source DB: PubMed Journal: Nat Rev Immunol ISSN： 1474-1733 Impact factor: 53.106

× No keyword cloud information.

13 in total

Review 1. Metronomic chemotherapy: new rationale for new directions.

Authors: Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal: Nat Rev Clin Oncol Date: 2010-06-08 Impact factor: 66.675

Review 2. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.

Authors: Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Sandra Demaria; Silvia Chiara Formenti; Guido Kroemer
Journal: Nat Rev Clin Oncol Date: 2016-11-15 Impact factor: 66.675

Review 3. Immunogenic cell death in cancer and infectious disease.

Authors: Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal: Nat Rev Immunol Date: 2016-10-17 Impact factor: 53.106

Review 4. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.

Authors: Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Beth Levine; Douglas R Green; Guido Kroemer
Journal: Nat Rev Drug Discov Date: 2017-05-19 Impact factor: 84.694

Review 5. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.

Authors: Malte Mohme; Sabine Riethdorf; Klaus Pantel
Journal: Nat Rev Clin Oncol Date: 2016-09-20 Impact factor: 66.675

6. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.

Authors: Jitka Fucikova; Iva Truxova; Michal Hensler; Etienne Becht; Lenka Kasikova; Irena Moserova; Sarka Vosahlikova; Jana Klouckova; Sarah E Church; Isabelle Cremer; Oliver Kepp; Guido Kroemer; Lorenzo Galluzzi; Cyril Salek; Radek Spisek
Journal: Blood Date: 2016-11-01 Impact factor: 22.113

Review 7. Immunogenic cell death and DAMPs in cancer therapy.

Authors: Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal: Nat Rev Cancer Date: 2012-11-15 Impact factor: 60.716

Review 8. Immunogenic cell death in cancer therapy.

Authors: Guido Kroemer; Lorenzo Galluzzi; Oliver Kepp; Laurence Zitvogel
Journal: Annu Rev Immunol Date: 2012-11-12 Impact factor: 28.527

9. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.

Authors: Bradley N Bidwell; Clare Y Slaney; Nimali P Withana; Sam Forster; Yuan Cao; Sherene Loi; Daniel Andrews; Thomas Mikeska; Niamh E Mangan; Shamith A Samarajiwa; Nicole A de Weerd; Jodee Gould; Pedram Argani; Andreas Möller; Mark J Smyth; Robin L Anderson; Paul J Hertzog; Belinda S Parker
Journal: Nat Med Date: 2012-07-22 Impact factor: 53.440

Reply: Immunosuppressive cell death in cancer.

Review 1. Metronomic chemotherapy: new rationale for new directions.

Review 2. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.

Review 3. Immunogenic cell death in cancer and infectious disease.

Review 4. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.

Review 5. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.

6. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.

Review 7. Immunogenic cell death and DAMPs in cancer therapy.

Review 8. Immunogenic cell death in cancer therapy.

9. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.

Review 10. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer.

1. Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math.

Review 2. Using immunotherapy to boost the abscopal effect.

Review 3. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.

Review 4. Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis.